Cholinesterase inhibitors in the treatment of dementia

International Journal of Geriatric Psychiatry

Volumn 18, Issue 5, 2003, Pages 458-459

  Margallo Lana, Maria Luisa ^a   Ballard, Clive ^a   Morris, Chris ^a   Kay, David ^a   Tyrer, Stephen ^a   Moore, Brian ^a  

^a TYNE AND WEAR NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR;

ALZHEIMER DISEASE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DEMENTIA; DISEASE COURSE; DOWN SYNDROME; DRUG EFFICACY; HUMAN; LETTER; MEMORY; NEUROPSYCHOLOGICAL TEST; PROSPECTIVE STUDY; RELIABILITY; VALIDATION PROCESS;

ADULT; CHOLINESTERASE INHIBITORS; COGNITION DISORDERS; DEMENTIA; DOWN SYNDROME; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 0038811743     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/gps.809     Document Type: Letter

References (3)

1. Kay DWK, Tyrer SP, Margallo-Lana ML, et al. Preliminary evaluation of a scale to assess cognitive function in adults with Down's syndrome: The Prudhoe Cognitive Function Test. J Intellect Disabil Res in press.
2. Prasher VP, Huxley A, Haque MS 2002. A 24-week, double blind placebo controlled trial of Donepezil in patients with Down syndrome and Alzheimer's disease-pilot study. Int J Geriatr Psychiatry 17(3): 270-278.
3. Prasher VP, Chung MC. 1996. Causes of age-related decline in adaptative behaviour of adults with Down's syndrome: Differential diagnoses of dementia. Am J Ment Retard 101(2): 175-183.